Lane Report

Who are the 26 new graduates of 2025’s HEN and AML Fellows programs at GLI

Health Enterprises Network (HEN) and Advanced Manufacturing and Logistics Network (AML) celebrated the graduation of 26 ...
Targeted Oncology

FDA Grants Orphan Drug Status to Novel CD33-Directed Immunotherapy for AML

M2T-CD33 (LTI-214) has received FDA orphan drug designation, offering incentives like tax credits and market exclusivity for AML treatment. The treatment targets CD33, a glycoprotein present in 90% of ...

Curis anticipates initial CLL proof-of-concept study data at ASH 2026 while advancing PCNSL and AML programs

Q3 2025 Management View James Dentzer, President and CEO, emphasized continued progress in the TakeAim Lymphoma study evaluating emavusertib in combination with ibrutinib in primary CNS lymphoma ...

Kura Oncology, Inc.: Kura Oncology Receives Second $30 Million Development Milestone Payment in AML Menin Inhibitor Program With Kyowa Kirin

Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment ...
JD Supra

Compliance Tip of the Day - Compliance Lessons from Citibank’s AML Program

This week, we continue our look at how companies are using AI in their business operations and draw compliance lessons from this use for compliance professionals. Today, we continue with compliance ...